Lantern Pharma amends CSO Bhatia's agreement: term to Jan 2026, reduced hours, $189,600 salary

Lantern Pharma Inc.

Kishor G. Bhatia, CSO, employment term extended to January 15, 2026.
Minimum weekly hours reduced to 24 for scientific, clinical, and therapeutic development.
Annual base salary proportionately adjusted to $189,600 effective first pay period January 2025.

item 5.02

Lantern Pharma Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-001685

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.